Maternal Serum Uric Acid as a Predictor of Severity of Hypertensive Disorders of Pregnancy: A Prospective Cohort Study

Author(s): Naina Kumar* , Amit K. Singh .

Journal Name: Current Hypertension Reviews

Volume 15 , Issue 2 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Objective: To assess the relationship between maternal serum uric acid and severity of Hypertensive disorders of pregnancy in a rural tertiary care centre.

Materials and Methods: Present study was conducted in Obstetrics and Gynaecology department of rural tertiary care centre of Northern India over seven months (October 2016-May 2017) on 110 women admitted with a Hypertensive disorder of pregnancy (Gestational hypertension, Preeclampsia, Eclampsia) at ≥34 weeks gestation. Maternal serum uric acid levels were compared in three groups in relation to disease severity, mode of delivery, maternal outcome.

Results: Of total 110 women with a Hypertensive disorder of pregnancy; 35 (31.81%) had Gestational Hypertension, 49 (44.54%) preeclampsia and 26 (23.63%) had eclampsia. Mean±SD values for serum uric acid were 5.47±1.93 mg/dl in women with Gestational Hypertension; 6.72±2.15 mg/dl in Pre-eclampsia and 8.71±2.97 mg/dl in the eclamptic group. Of 110 women 34(97.14%) with gestational hypertension, 27(55.10%) with pre-eclampsia and one (3.85%) with eclampsia remained stable in post-partum period, 17 (34.69%) women with severe pre-eclampsia and 15 (57.69%) with eclampsia required intensive care in postpartum period and one (2.86%) women with gestational hypertension, five (10.20%) with pre-eclmapsia and ten (38.46%) with eclampsia required ventilator support and high dependency unit care. Of these 16 women with the severe disease, ten succumbed to death. Also, in women with serum uric acid,>6mg/dl, most common mode of delivery was a lower segment cesarean section (50.90%).

Conclusion: Significant correlation was observed between maternal serum uric acid, disease severity and maternal outcome.

Keywords: Caesarean section, eclampsia, hypertension, pre-eclapmsia, uric acid, pregnancy.

[1]
Ugwuja EI, Famurewa AC, Ikaraoha CI. Comparison of serum calcium and magnesium between preeclamptic and normotensive pregnant Nigerian women in Abakaliki, Nigeria. Ann Med Health Sci Res 2016; 6(1): 33-7.
[2]
Cantwell R, Clutton-Brock T, Cooper G, et al. Saving mothers’ lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011; 118(Suppl. 1): 1-203.
[3]
Jain S, Sharma P, Kulshreshtha S, Mohan G, Singh S. The role of calcium, magnesium, and zinc in pre-eclampsia. Biol Trace Elem Res 2010; 133(2): 162-70.
[4]
Kooffreh ME, Ekott M, Ekpoudom DO. The prevalence of pre-eclampsia among pregnant women in the University of Calabar Teaching Hospital, Calabar. Saudi J Health Sci 2014; 3: 133-6.
[5]
Aabidha PM, Cherian AG, Paul E, Helan J. Maternal and fetal outcome in pre-eclampsia in a secondary care hospital in South India. J Family Med Prim Care 2015; 4(2): 257-60.
[6]
Carty DM, Delles C, Dominiczak AF. Preeclampsia and future maternal health. J Hypertens 2010; 28(7): 1349-55.
[7]
Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: Pathophysiology, diagnosis, and management. Vasc Health Risk Manag 2011; 7: 467-74.
[8]
Jido TA, Yakasai IA. Preeclampsia: A review of the evidence. Ann Afr Med 2013; 12(2): 75-85.
[9]
von Dadelszen P, Magee LA. Preventing deaths due to the hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2016; 36: 83-102.
[10]
Yalamati P, Bhongir AV, Betha K, Verma R, Dandge S. Relationship of serum uric acid, serum creatinine and serum cystatin C with maternal and fetal outcomes in rural Indian pregnant women. Int J Reprod Contracept Obstet Gynecol 2015; 4(5): 1505-10.
[11]
Kondareddy T, Prathap T. Uric acid as an important biomarker in hypertensive disorders in pregnancy. Int J Reprod Contracept Obstet Gynecol 2016; 5: 4382-4.
[12]
Zangana JM, Hamadamen AI. Serum uric acid as a predictor of perinatal outcome in women with pre-eclampsia. Int J Med Res Health Sci 2018; 7(3): 168-74.
[13]
Hawkins TL, Roberts JM, Mangos GJ, Davis GK, Roberts LM, Brown MA. Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: A retrospective cohort study. BJOG 2012; 119(4): 484-92.
[14]
Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor in preeclampsia. Placenta 2008; 29(Suppl. A): S67-72.
[15]
Bulusu R, Singh T. Analysis of serum uric acid levels in early second trimester as an early predictor for preeclampsia. J Evid Based Med Healthc 2017; 4(3): 115-8.
[16]
Johnson RJ, Kanbay M, Kang DH, Lozada LGS, Feig D. Uric acid: A clinically useful marker to distinguish preeclampsia from gestational hypertension. Hypertension 2011; 58(4): 548-9.
[17]
Laughon SK, Catov J, Powers RW, Roberts JM, Gandley RE. First-trimester uric acid and adverse pregnancy outcomes. Am J Hypertens 2011; 24(4): 489-95.
[18]
NICE clinical guideline 107. Hypertension in pregnancy: The management of hypertensive disorders during pregnancy [Internet] [Issued: August 2010; last modified: January 2011; Cited 2014 January 16]. Available from: www.nice.org.uk/nicemedia/live/13098/ 50418/50418.pdf
[19]
Committee on Obstetric Practice. Committee Opinion No. 692: Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol 2017; 129(4): e90-5.
[20]
[Guideline] American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy.. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122(5): 1122-31.
[21]
Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: A reference table for clinicians. Obstet Gynecol 2009; 114(6): 1326-31.
[22]
Andrews L, Mehta L, Sharma A, Haridas N, Vaishnav S, Jadav P. Maternal outcome in relation to biochemical parameters in hypertensive disorders in pregnancy. IOSR-JDMS 2014; 13(2): 18-22.
[23]
Koley A, Das S, Sarkar S, Char D, Saha TK. Association of serum calcium and uric acid level with hypertensive disorders of pregnancy [pre-eclampsia and eclampsia] and their correlation with disease severity. IOSR-JDMS 2013; 9(5): 32-5.
[24]
Ahmed QN, Dewan F. Effect of raised serum uric acid level on perinatal and maternal outcome in cases of pregnancy-induced hypertension. Bangabandhu Sheikh Mujib Med Univ J 2017; 10(2): 58-60.
[25]
Chaturvedi S, Randive B, Mistry N. Availability of treatment for eclampsia in public health institutions in Maharashtra, India. J Health Popul Nutr 2013; 31(1): 86-95.
[26]
Rani K, Prasad MK, Bisht V. Eclampsia a major burden on maternal and child health: a retrospective study in tertiary care centre. J Evid Based Med Healthc 2017; 4(6): 311-5.
[27]
Halimi S, Halimi SM. Eclampsia and its association with external factors. J Ayub Med Coll Abbottabad 2010; 22(3): 110-2.
[28]
Shen M, Smith GN, Rodger M, White RR, Walker MC, Wen SW. Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsia. PLoS One 2017; 12(4): e0175914.
[29]
Browne JL, Vissers KM, Antwi E, et al. Perinatal outcomes after hypertensive disorders in pregnancy in a low resource setting. Trop Med Int Health 2015; 20(12): 1778-86.
[30]
Chaurasia PP, Jadav PA, Jasani JH. Changed in serum calcium and serum magnesium level in pre-eclamptic vs. normal pregnancy. IJBAR 2012; 3(6): 511-3.
[31]
Kanagal DV, Rajesh A, Rao K, et al. Levels of serum calcium and magnesium in pre-eclamptic and normal pregnancy: A study from coastal India. J Clin Diagn Res 2014; 8(7): OC01-4.
[32]
Kumar N, Singh AK, Maini B. Impact of maternal serum uric acid on perinatal outcome in women with hypertensive disorders of pregnancy: A prospective study. Pregnancy Hypertens 2017; 10: 220-5.
[33]
Singh S, Ahmed EB, Egondu SC, Ikechukwu NE. Hypertensive disorders in pregnancy among pregnant women in a Nigerian Teaching Hospital. Niger Med J 2014; 55(5): 384-8.
[34]
Sachan R, Patel ML, Sachan P, Gaurav A, Singh M, Bansal B. Outcomes in hypertensive disorders of pregnancy in the North Indian population. Int J Womens Health 2013; 5: 101-8.
[35]
Wolde Z, Segni H, Woldie M. Hypertensive disorders of pregnancy in Jimma University Specialized Hospital. Ethiop J Health Sci 2011; 21(3): 147-54.
[36]
Patel T, Dudhat A. Relationship of serum uric acid level to maternal and perinatal outcome in patients with hypertensive disorders of pregnancy. GMJ 2014; 69(2): 45-7.
[37]
Khosla AH, Dahiya K, Sangwan K. Maternal mortality and ‘near-miss’ in rural north India. Int J Gynaecol Obstet 2000; 68(2): 163-4.
[38]
Nakimuli A, Nakubulwa S, Kakaire O, et al. The burden of maternal morbidity and mortality attributable to hypertensive disorders in pregnancy: A prospective cohort study from Uganda. BMC Pregnancy Childbirth 2016; 16: 205.
[39]
Das R, Biswas S. Eclapmsia: The major cause of maternal mortality in eastern India. Ethiop J Health Sci 2015; 25(2): 111-6.
[40]
Pereira KN, Knoppka CK, da Silva JE. Association between uric acid and severity of pre-eclampsia. Clin Lab 2014; 60(2): 309-14.
[41]
Thanna RC, Choudhary R, Pathak S, Vamne A, Nigoskaret S. Level of serum acid in preeclampsia. Int J Clin Biochem 2015; 2(2): 120-2.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 15
ISSUE: 2
Year: 2019
Page: [154 - 160]
Pages: 7
DOI: 10.2174/1573402114666181112141953

Article Metrics

PDF: 34
HTML: 3